-The Hindu Business Line India’s manufacturing needs higher investment in education and R&D to become self-reliant and technologically competent The share of manufacturing in India’s GDP has stagnated at 16 per cent since 1991, despite economic reforms. No country ever became a manufacturing force without (a) a design capability; and (b) an institutional system that incentivises and sustains innovations. India needs a system to develop human and technical capabilities at both the...
More »SEARCH RESULT
India trashes US report, calls it attack on cheap generic drugs -Sushmi Dey
-The Times of India NEW DELHI: India has outrightly rejected allegations in a US report about the country being a chief source of counterfeit medicines to the world and said it is an attack on low cost generic drugs — crucial to make healthcare affordable. The ‘Special 301 Report’ by United States Trade Representative (USTR) slammed India and China as leading sources of counterfeit medicines distributed globally with 20% of all pharmaceutical...
More »Many essential drugs priced much higher than Manufacturing Cost: WHO -Sushmi Dey
-The Times of India NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows highlighting the “exorbitant” profiteering by pharmaceutical companies and the scope for lowering prices of drugs. While innovative and newer drugs for cancer, hepatitis C and rare diseases are out of reach of many due to their unaffordable prices,...
More »To shield patents, firms seek information on generic drug launches -Sushmi Dey
-The Times of India NEW DELHI: In what is being seen as an attempt to delay launch of low priced generic medicines, multinational drug makers have asked the government to create a registry providing information about all drug applications pending manufacturing and marketing approval. The proposal, if accepted by the government, will help ‘big pharma’ pre-emptively challenge generic drug makers in court for allegedly infringing upon their patents and in turn blocking...
More »Without Rise in Farm Income, Congress' Loan Waivers Won't End Rural Distress -Kabir Agarwal
-TheWire.in Implementing the loan waiver in Chhattisgarh, MP and Rajasthan will not be easy. It will cost Rs 80,000 crore and might need the states to double the spending on agriculture. New Delhi: On Monday, the newly appointed chief minister of Madhya Pradesh, Kamal Nath, proudly announced that his first executive decision was to waive farm loans in the state. While campaigning for the assembly elections, the Congress party had promised that if...
More »